Molecular Pathology Laboratory Network, Inc. (MPLN)
Roger A. Hubbard has had a diverse work experience. Roger A. started their career in 1989 as the Chief Executive Officer of Molecular Pathology Laboratory Network, Inc. (MPLN). In 2007, they founded Geneuity Clinical Research Services and served as its Chief Executive Officer. In 1995, they joined the University of Tennessee Graduate School of Medicine/Knoxville as a Clinical Associate Professor in the Department of Pathology. Since 2012, they have been working as a Clinical Professor in the Department of Pathology at the East Tennessee State University James H. Quillen College of Medicine.
Roger A. Hubbard obtained their Bachelor of Science (BS) degree in microbiology from the University of Tennessee, Knoxville, where they studied from 1970 to 1974. Roger A. then pursued a Master of Science (MS) degree in microbiology from the same institution, completing their studies from 1976 to 1978. Hubbard furthered their education by pursuing a Doctor of Philosophy (PhD) degree in biochemistry/molecular biology at the Medical University of South Carolina, where they studied from 1982 to 1988.
Molecular Pathology Laboratory Network, Inc. (MPLN)
Molecular Pathology Laboratory Network (MPLN) has been at the forefront of laboratory medicine since its inception in 1989 and inspired the genesis of women’s health testing using molecular diagnostics and technology. For decades, MPLN has continued to lead the way in specialty testing with an emphasis on women’s health and oncology. MPLN strives to be the best client experience in laboratory medicine by bringing you comprehensive specialty testing, informatics using the latest digital applications, and unparalleled customer service. Our history is rich and rooted in our foundation of providing the very best in patient care, by exploring, developing, and delivering innovative solutions and technologies that elevate our field. Providing an expanding menu of molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization and cytogenetic testing, MPLN is dedicated to providing superior diagnostic services to our clients in pathology groups, hospitals, medical laboratories and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide: · High-quality, timely results · Cost-effective testing strategies · Personalized consultative testing services from Board Certified Hematopathologists · Responsive and professional customer service